摘要:
The present invention relates to a method for the diagnostic and/or prognostic of a neurological disease characterized by an inflammation process in a subject comprising measuring the amount of myeloid derived microvesicles in a cerebrospinal fluid sample obtained from the subject. The invention further relates to a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology or for monitoring a neurological disease progression.